BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6193593)

  • 21. [Role of the classical and alternative complement pathways in chemotaxis of human C2 deficiency (author's transl)].
    Pham Huu T; Buriot D; Griscelli C
    Ann Immunol (Paris); 1980; 131C(1):69-77. PubMed ID: 7396417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Studies on the mobilities of granulocytes and the chemotactic factor production by human mononuclear cells (author's transl)].
    Nakayama M
    Hokkaido Igaku Zasshi; 1981 Mar; 56(2):217-31. PubMed ID: 7327510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotaxis of polymorphonuclear leukocytes in response to surface-bound complement-derived chemoattractants generated in situ.
    Dahlgren C; Hed J; Stendahl O
    Inflammation; 1984 Jun; 8(2):201-8. PubMed ID: 6378792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Superoxide-dependent chemotactic activity for PMNs derived from opsonized zymosan-stimulated human platelets.
    Del Principe D; Menichelli A; Galli E; Persiani M; Perlini R; D'Arcangelo C; Businco L; Rossi P
    Pediatr Res; 1982 Dec; 16(12):1000-3. PubMed ID: 6296752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of a fibroblast chemotactic factor in serum by activation of complement.
    Postlethwaite AE; Snyderman R; Kang AH
    J Clin Invest; 1979 Nov; 64(5):1379-85. PubMed ID: 91624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of transepidermal leukocyte chemotaxis in experimental dermatophytosis in guinea pigs.
    Tagami H; Natsume N; Aoshima T; Inoue F; Suehisa S; Yamada M
    Arch Dermatol Res; 1982; 273(3-4):205-17. PubMed ID: 7165350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dextranomer (Debrisan) paste in post-operative wounds. A controlled study.
    Michiels I; Christiaens MR
    Clin Trials J; 1990; 27(4):283-90. PubMed ID: 10148140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coagulation impact on chemotactic activity generation for polymorphonuclear leukocytes.
    Morin A; Arvier MM; Doutremepuich F; Vigneron C
    Thromb Res; 1990 Sep; 59(6):979-84. PubMed ID: 2264022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemotactic migration of leucocytes through corneal layers: an in vitro study.
    Basu PK; Minta JO
    Can J Ophthalmol; 1976 Jul; 11(3):235-40. PubMed ID: 949633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of methylmethacrylate on chemotaxis of polymorphonuclear leukocytes.
    Petty W
    J Bone Joint Surg Am; 1978 Jun; 60(4):492-8. PubMed ID: 353058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on healing of Debrisan-treated wounds.
    Jacobsson S; Jonsson L; Rank F; Rothman U
    Scand J Plast Reconstr Surg; 1976; 10(2):97-101. PubMed ID: 1019590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphonuclear leukocyte chemotaxis in psoriasis: enhancement by self-activated serum.
    Kawohl G; Szperalski B; Schröder JM; Christophers E
    Br J Dermatol; 1980 Nov; 103(5):527-33. PubMed ID: 7437318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An evaluation of dextranomer as a cleansing agent in the treatment of the post-phlebitic stasis ulcer.
    Groenewald JH
    S Afr Med J; 1980 May; 57(20):809-15. PubMed ID: 6157197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotactic peptides modulate adherence of human polymorphonuclear leukocytes to monolayers of cultured endothelial cells.
    Charo IF; Yuen C; Perez HD; Goldstein IM
    J Immunol; 1986 May; 136(9):3412-9. PubMed ID: 3514759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutrophil chemotaxis in patients with Staphylococcus aureus furunculosis.
    Cates KL; Quie PG
    Infect Immun; 1979 Dec; 26(3):1004-8. PubMed ID: 393626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low molecular weight eosinophil chemotactic factor (ECF) production by rat peritoneal mononuclear phagocytes.
    Czarnetzki BM
    Immunobiology; 1980 Apr; 157(1):62-6. PubMed ID: 6782008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defective polymorphonuclear leucocyte chemotaxis in rheumatoid arthritis associated with a serum inhibitor.
    Hanlon SM; Panayi GS; Laurent R
    Ann Rheum Dis; 1980 Feb; 39(1):68-74. PubMed ID: 6990882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defective serum chemotactic capacity in rheumatoid arthritis.
    Attia WM; Ali MK; Abu-Ghazalah LM; Shams AH; Clark HW; Brown TM; Bellanti JA
    Ann Allergy; 1983 Apr; 50(4):266-70. PubMed ID: 6838025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Random and directed migration of trout (Salmo gairdneri) leukocytes: activation by antibody, complement, and normal serum components.
    Griffin BR
    Dev Comp Immunol; 1984; 8(3):589-97. PubMed ID: 6500137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bovine peripheral blood polymorphonuclear neutrophil chemotactic response to Pasteurella haemolytica or zymosan-activated serum.
    Bruecker KA; Schwartz LW
    Am J Vet Res; 1982 Oct; 43(10):1879-81. PubMed ID: 7149395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.